Control group n = 66 | RIPC group n = 66 | P-value | |
---|---|---|---|
Primary endpoint | |||
Increase in cystatin C ≥ 10% after 48–72 h, n (%) | 24 (36.4) | 24 (36.4) | 1 |
Secondary endpoints | |||
Contrast-induced acute kidney injury, n (%) | 4 (6.1) | 2 (3) | 0.68 |
Serum creatinine after 48–72 h (mg/dL) | 1.4 (1.25–1.53) | 1.4 (1.2–1.54) | 0.92 |
Change in serum creatinine after 48–72 h (mg/dL) | −0.11 (−0.3 to 0) | −0.165 (−0.31 to 0) | 0.53 |
Cystatin C after 48–72 h (mg/L) | 1.4 (1.12–1.74) | 1.55 (1.22–2) | 0.13 |
Cystatin C change after 48–72 h | + 0.065 (− 0.185 to + 0.3) | − 0.01 (− 0.357 to + 0.387) | 0.59 |
Clinical endpoints | |||
Re-admission within 2 months n (%) | 18 (27.3) | 16 (24.2) | 1 |
Dialysis within 2 months n (%) | 0 | 0 | n.a. |
Mortality within 2 months n (%) | 1 (1.5) | 0 | 0.69 |